Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Pognat

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Arzneimittel-Forschung|January 1, 1978
Pharmacokinetics of amixetrine in the dog. Relation of dose-to-plasma concentrationM Constantin, J F Pognat
Arzneimittel-Forschung|January 1, 1979
Comparative study of oxaflozane urinary metabolism in man, the dog and the rat. Identification of the principal metabolitesM Constantin, J F Pognat
Arzneimittel-Forschung|January 1, 1978
Zipeprol metabolism in man and in the animalM Constantin, J F Pognat
Arzneimittel-Forschung|January 1, 1976
Urinary metabolites of amixetrine in man and in the dogM Constatin, J F Pognat, G Streichenberger
European Journal of Drug Metabolism and Pharmacokinetics|July 14, 2005
Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or "TEER, a measurement of toxicity?"F Mathieu, M J Galmier, J F Pognat, et al.
Pharmacology|January 1, 1984
Multiple binding of bepridil in human bloodE Albengres, S Urien, J F Pognat, et al.
International Journal of Pharmaceutics|June 17, 1999
Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSSF Mathieu, M J Galmier, J F Pognat, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 25, 2003
Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using a "dynamic model"F Mathieu, M J Galmier, A Nicolay, et al.
Pharmacological Research|April 1, 1993
An in vitro investigation of the relationships between potency, lipophilicity, cytotoxicity and chemical class of representative calcium antagonist drugsG W John, R Shrivastava, A Chevalier, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1983
[Effect of bepridil on the heart rate of the healthy subject. Correlation with plasma levels]J P Kantelip, P Duchène-Marullaz, J F Trolèse, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Arzneimittel-Forschung|January 1, 1978
Pharmacokinetics of amixetrine in the dog. Relation of dose-to-plasma concentrationM Constantin, J F Pognat
Arzneimittel-Forschung|January 1, 1979
Comparative study of oxaflozane urinary metabolism in man, the dog and the rat. Identification of the principal metabolitesM Constantin, J F Pognat
Arzneimittel-Forschung|January 1, 1978
Zipeprol metabolism in man and in the animalM Constantin, J F Pognat
Arzneimittel-Forschung|January 1, 1976
Urinary metabolites of amixetrine in man and in the dogM Constatin, J F Pognat, G Streichenberger
European Journal of Drug Metabolism and Pharmacokinetics|July 14, 2005
Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or "TEER, a measurement of toxicity?"F Mathieu, M J Galmier, J F Pognat, et al.
Pharmacology|January 1, 1984
Multiple binding of bepridil in human bloodE Albengres, S Urien, J F Pognat, et al.
International Journal of Pharmaceutics|June 17, 1999
Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSSF Mathieu, M J Galmier, J F Pognat, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 25, 2003
Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using a "dynamic model"F Mathieu, M J Galmier, A Nicolay, et al.
Pharmacological Research|April 1, 1993
An in vitro investigation of the relationships between potency, lipophilicity, cytotoxicity and chemical class of representative calcium antagonist drugsG W John, R Shrivastava, A Chevalier, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1983
[Effect of bepridil on the heart rate of the healthy subject. Correlation with plasma levels]J P Kantelip, P Duchène-Marullaz, J F Trolèse, et al.
Pageof 2